BioAdaptives Valuation

Is BDPT.D undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BDPT.D when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BDPT.D's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BDPT.D's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BDPT.D?

Key metric: As BDPT.D is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BDPT.D. This is calculated by dividing BDPT.D's market cap by their current revenue.
What is BDPT.D's PS Ratio?
PS Ratio	10.3x
Sales	US$19.87k
Market Cap	US$205.29k

BDPT.D key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	25.8x
Enterprise Value/EBITDA	-1.5x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does BDPT.D's PS Ratio compare to its peers?

The above table shows the PS ratio for BDPT.D vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	8.7x
SMFL Smart for Life	0.04x	n/a	US$319.1k
BFYW Better For You Wellness	28.7x	n/a	US$522.0k
MNKA Manuka	0.4x	n/a	US$235.3k
LQWC LifeQuest World	5.7x	n/a	US$841.7k
BDPT.D BioAdaptives	10.3x	n/a	US$205.3k

Price-To-Sales vs Peers: BDPT.D is expensive based on its Price-To-Sales Ratio (10.3x) compared to the peer average (8.7x).

Price to Sales Ratio vs Industry

How does BDPT.D's PS Ratio compare vs other companies in the US Personal Products Industry?

26 Companies	Price / Sales	Estimated Growth	Market Cap
HLF Herbalife	0.2x	1.8%	US$848.67m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$358.91m
MED Medifast	0.3x	-13.4%	US$196.10m
SKIN Beauty Health	0.5x	5.7%	US$176.25m

26 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Sales vs Industry: BDPT.D is expensive based on its Price-To-Sales Ratio (10.3x) compared to the US Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is BDPT.D's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BDPT.D PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	10.3x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BDPT.D's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Beauty Health

US$176.3m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.42

-7.2%

-40.1%

Oddity Tech

US$2.6b

Operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally.

ODD

US$45.56

14.6%

32.5%

Reynolds Consumer Products

US$5.8b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.76

1.9%

6.4%